Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2 (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2024.101695
Publication URI: http://dx.doi.org/10.1016/j.xcrm.2024.101695
Type: Journal Article/Review
Parent Publication: Cell Reports Medicine
Issue: 9